New therapies driven by a fusion of science and industry

Happy Cell Factory

Improved therapies through the fusion of science and industry

The Fraunhofer IPT has many years of experience and expertise in automated cell cultivation and special machine development. The close collaboration between research and practice results in innovative technologies for the production of new gene and cell therapeutics that drive the pharmaceutical industry forward.

In this cooperation, we combine technical expertise and outstanding research results to develop marketable and efficient solutions for the production of ATMPs. Our aim is to meet the increasing demands for quality, safety and efficiency. Together, we offer comprehensive advice on automation and plant planning, GMP plant engineering for industrial pharmaceutical production and worldwide service for production plants.

Benefit from the advantages

Solutions from the laboratory to commercial production, whether batch size one or serial production
Accelerated market launch
State-of-the-art research services from Fraunhofer IPT
Modular, flexible GMP solutions from Harro Höfliger

Fraunhofer IPT: Process audit, scientific consulting, and evaluation.

Fraunhofer IPT X Harro Höfliger: Concept development, PoP work, and development of the upscale strategy.

Harro Höfliger: Equipment building with support from Fraunhofer, followed by worldwide service.

Combined expertise

In collaboration with Harro Höfliger, a leader in automation solutions for the pharmaceutical and medtech industries, we have developed advanced technologies that can transform your production processes. By addressing the critical challenges of the ATMP market, our automation solutions offer unparalleled workflow flexibility, long-term cost savings, and seamless compliance with stringent regulations, including documentation and traceability.

Our combined expertise allows us to tackle the complexities of scaling up production while ensuring the highest levels of accuracy and reproducibility. This means you can focus on delivering life-saving therapies with confidence, knowing that your processes are optimized for both current and future demands.

To the video

Please feel free to contact me with any questions or to schedule a meeting. We look forward to the possibility of collaborating with you to revolutionize your CAR-T cell operations.

Any questions?

Christian Kollecker

Director Sales Aseptic Processing

christian.kollecker@hoefliger.de

Interesting for you

Cell and gene therapies

The production of ATMPs (Advanced Therapy Medicinal Products) of the highest quality requires individual production facilities and specific services. The focus here is on careful handling of the cell material.

Pharma Services

When and how does process reliability emerge for your new formulations and innovative devices? The earlier, the better. With combined expertise from research, development, and mechanical engineering for efficient, risk-minimized process development.